What Is the Risk of Secondary Cancers in CLL Patients?
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
Can Vaccinations Cause a CLL Flare?
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
What Are the Signs of Richter’s Transformation?
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
CLL Global Virtual Town Hall: September 12, 2024
Experts discussed the latest advances in CLL clinical trials highlighted at the 2021 American Society of Hematology (ASH) meeting, the world’s premier conference in hematology.
What Makes the CLL Global Research Foundation Unique?
William Wierda, President and CEO, discusses the ways in which the CLL Global Research Foundation is different and how the organization’s collaborative spirit advances CLL research.
CLL Global Research Foundation President | Dr. William Wierda
William Wierda, President and CEO of the CLL Global Research Foundation discusses his hope for the future of the organization.
What CLL Patients Should Know About RSV and COVID Vaccines
Experts respond to a viewer question about vaccinations for COVID and RSV as it relates to people with CLL.
Is CLL Now a Highly Treatable Condition?
Dr. William Wierda and Dr. Patrick Reville discussed the long-term treatment and management of CLL.
Understanding Data from the TRANSCEND Trial | CAR T-Cell Therapy for CLL
Experts responded to viewer questions about CAR T-cell therapy during the Feb 7, 2024 virtual town hall.
How Is CLL Treatment Guided by Cytogenetic Testing?
Experts responded to viewer questions about CLL and cytogenetic testing during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.